Phase 2 open-label extention (OLE) study of patisiran, an investigational siRNA agent for familial amyloidotic polyneuropathy (FAP).
about
Phase 2 open-label extention (OLE) study of patisiran, an investigational siRNA agent for familial amyloidotic polyneuropathy (FAP).
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Phase 2 open-label extention ( ...... loidotic polyneuropathy (FAP).
@en
Phase 2 open-label extention ( ...... loidotic polyneuropathy (FAP).
@nl
type
label
Phase 2 open-label extention ( ...... loidotic polyneuropathy (FAP).
@en
Phase 2 open-label extention ( ...... loidotic polyneuropathy (FAP).
@nl
prefLabel
Phase 2 open-label extention ( ...... loidotic polyneuropathy (FAP).
@en
Phase 2 open-label extention ( ...... loidotic polyneuropathy (FAP).
@nl
P2093
P1476
Phase 2 open-label extention ( ...... yloidotic polyneuropathy (FAP)
@en
P2093
David Adams
Josep Campistol
Juan Buades
Marcia Waddington-Cruz
Ole B Suhr
Teresa Coehlo
P2888
P304
P356
10.1186/1750-1172-10-S1-O20
P433
P577
2015-11-02T00:00:00Z
P6179
1039339108